EMPOWER 3: Improving Palliative Care Health Literacy and Utilization

Study acronym: EMPOWER 3
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Apr 30, 2026 to Oct 10, 2025
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 1 of 5 entries
  2. Primary completion date: Apr 2025 to Apr 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Aug 2025 to Aug 31, 2026
    • Site details revised at 2 of 2 sites
    v8
  3. Eligibility criteria expanded, about 26 words
    • Site contacts updated at 2 of 2 sites
    v7
  4. 2 versions Re-verified since Apr 25, 2022, no change to tracked fieldsv5-v6
  5. Start date changed from estimate of Mar 2021 to Mar 31, 2021v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Feb 2021 to Mar 2021v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Through this award, Michael Hoerger, PhD, MSCR, a psychologist at the Tulane Cancer Center in Louisiana, will lead a study called EMPOWER 3 designed to test an educational intervention to help patients understand palliative care, use it, and feel better emotionally and physically. Participants will be adults with serious cancer diagnoses. Participants will be randomized into two groups. Patients in the control group will get enhanced usual care, meaning standard cancer care and several additional healthcare-related brochures. Patients in the intervention group will get enhanced usual care plus an educational video developed by the investigators and other materials designed to increase understanding and use of palliative care. Family members of patients in the intervention group may also attend if desired. The investigators will track participants' understanding of palliative care, attitudes toward palliative care, symptoms over 6 months of follow-up, and palliative care utilization.
Trial Details
NCT Number NCT04733469
Lead Sponsor Tulane University
Collaborators: American Cancer Society, Inc., University Medical Center New Orleans
Conditions
(from sponsor)		 Cancer, Neoplasm Malignant
Related terms Neoplasms
Enrollment 172 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov